E-LIB Suche - Ergebnisse für: Albert Oriol

1

Subcutaneous daratumumab in patients with relapsed or refra..:

Jesus San-Miguel ; Saad Z. Usmani ; Maria-Victoria Mateos...
Haematologica. 106 (2020) 6 - p. 1725-1732 , 2020

Link: https://doi.org/10.3324/..

2

An open-label phase 2 study treating patients with first or..:

Perrot, Aurore ; Delimpasi, Sosana ; Spanoudakis, Emmanouil...
Leukemia & Lymphoma. 65 (2024) 6 - p. 833-842 , 2024

Link: https://doi.org/10.1080/..

3

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide..:

Oriol, Albert ; Dimopoulos, Meletios ; Schjesvold, Fredrik...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 3 - p. 165-176.e4 , 2024

Link: https://doi.org/10.1016/..

4

Selinexor, daratumumab, bortezomib and dexamethasone for th..:

González-Calle, Verónica ; Rodríguez-Otero, Paula ; Sureda, Anna...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

5

Nivolumab, Pomalidomide, and Elotuzumab Combination Regimen..:

Oriol, Albert ; Hájek, Roman ; Spicka, Ivan...
Clinical Lymphoma Myeloma and Leukemia. , 2024

Link: https://doi.org/10.1016/..

6

Teclistamab Improves Patient-Reported Symptoms and Health-R..:

Martin, Thomas G. ; Moreau, Philippe ; Usmani, Saad Z....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 3 - p. 194-202 , 2024

Link: https://doi.org/10.1016/..

7

CD200 genotype is associated with clinical outcome of patie..:

Gonzalez-Montes, Yolanda ; Osca-Gelis, Gemma ; Rodriguez-Romanos, Rocío...
Frontiers in Immunology. 15 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

8

Safety and efficacy of belantamab mafodotin with pembrolizu..:

Suvannasankha, Attaya ; Bahlis, Nizar ; Trudel, Suzanne...
Cancer. 130 (2024) 15 - p. 2629-2641 , 2024

Link: https://doi.org/10.1002/..

9

Digitale Gesundheitsplattformen – Beispiele für Datenmanage..:

, In: Health Data Management,

Oriol, Albert ; Meier, Pierre-Michael ; Ebling, Frank... - p. 441-454 , 2024

Link: https://doi.org/10.1007/..

10

Single-point and kinetics of peripheral residual disease by..:

Puig, Noemí ; Agulló, Cristina ; Contreras, Teresa...
Haematologica. , 2024

Link: https://doi.org/10.3324/..

11

P-306 Final results of a Phase 1b study of subcutaneous isa..:

Quach, Hang ; Parmar, Gurdeep ; Ocio, Enrique...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S206-S207 , 2023

Link: https://doi.org/10.1016/..

12

Plain language summary of the MajesTEC-1 study of teclistam..:

Moreau, Philippe ; van de Donk, Niels WCJ ; Nahi, Hareth...
Future Oncology. 19 (2023) 12 - p. 811-818 , 2023

Link: https://doi.org/10.2217/..

13

POSTER: MM-163 Long-Term Follow-Up From MajesTEC-1 of Tecli..:

van de Donk, Niels ; Moreau, Philippe ; Garfall, Alfred...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S224 , 2023

Link: https://doi.org/10.1016/..

14

P883: ALNUCTAMAB (ALNUC; BMS-986349; CC-93269), A BCMA × CD..:

Wong, Sandy W. ; Bar, Noffar ; Victoria Mateos, María...
HemaSphere. 7 (2023) S3 - p. e1220745 , 2023

Link: https://doi.org/10.1097/..

15

P-110 Ixazomib maintenance in transplant-ineligible patient..:

Dimopoulos, Meletios ; Chng, Wee Joo ; Iida, Shinsuke...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S95 , 2023

Link: https://doi.org/10.1016/..